Cytokinetics Inc. buy Royal Bank of Canada
Start price
11.11.25
/
50%
€55.50
Target price
11.11.26
€75.30
Performance (%)
0.90%
Price
15:36
€56.00
Summary
This prediction is currently active. Since the start of the prediction for Cytokinetics Inc. the price has only changed by 0.90%. This prediction currently runs until 11.11.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 0.507% | 0.507% |
| iShares Core DAX® | 0.789% | 1.975% |
| iShares Nasdaq 100 | 4.226% | 4.344% |
| iShares Nikkei 225® | 3.285% | 6.991% |
| iShares S&P 500 | 2.496% | 2.759% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at Royal Bank Of Canada from $82.00 to $87.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€45.80
18.12.24
18.12.24
€78.17
18.12.25
18.12.25
14.63%
19.12.25
19.12.25
